symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
KA,3.69,0,32131,38098881,10.01,1.78-15.54,0.07,"Kineta, Inc.",USD,0001445283,,,NASDAQ Capital Market,NASDAQ,Biotechnology,https://kinetabio.com,"Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.",Dr. Shawn P.  Iadonato Ph.D.,Healthcare,US,11,206 378 0400,219 Terry Ave. N,Seattle,WA,98109,,0,https://financialmodelingprep.com/image-stock/KA.png,2016-02-11,False,False,True,False,False
